Clinical Trial

Effectiveness of MST Versus ECT for Major Depressive Episode

Recruiting
View on ClinicalTrials.gov →
Summary
Despite advancements in Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT) for Major Depressive Disorder (MDD), there remains a need for further research to replicate clinical outcomes and understand the therapeutic targets of these treatments. This study aims to address these gaps through a double-blinded, randomized, non-inferiority investigation comparing the efficacy, tolerability, cognitive adverse effects, and neurophysiological biomarkers of MST and bilateral ECT in patients with MDD.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-07; most recent amendment 2024-08-21.
Status change: Not Yet Recruiting → Recruiting 2024-08-21
Trial Details
NCT Number NCT06409325
Lead Sponsor Shanghai Mental Health Center
Conditions Major Depressive Disorder (MDD)
Enrollment 210 participants
Start Date 2024-08-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-22